You are on page 1of 2

Table.

Add-on treatment options for acute asthma
Agent Recommended use in acute Administration and dosage Notes
asthma

Inhaled ipratropium Second-line bronchodilator if Via pMDI Adults and children Use spacer (plus
bromide inadequate response to 21 mcg/actuation 6 years and over: mask, if patient
salbutamol every 20 minutes 8 puffs cannot use
for rst hour Children 0–5 years: mouthpiece)
Repeat every 4– 4 puffs
6 hours for
24 hours

 
 

Via nebuliser Adults and children If salbutamol is
every 20 minutes 6 years and over: delivered by
for rst hour 500 mcg nebule nebuliser, add to
Repeat every 4– Children 0–5 years: nebuliser solution
6 hours 250 mcg nebule

IV magnesium sulfate Second-line bronchodilator in IV infusion over Adults: 10 mmol Avoid magnesium
severe or life-threatening 20 minutes Children 2 years and sulfate in children
acute asthma, or when poor over: 0.1– younger than 2 years
response to repeated maximal 0.2 mmol/kg Dilute in compatible
doses of other bronchodilators (maximum 10 mmol) solution
Agent Recommended use in acute Administration and dosage Notes
asthma

IV salbutamol Third-line bronchodilator in Follow hospital/organisation’s protocol  Use only in critical
(only in ICU) life-threatening acute asthma   care units (e.g.
that has not responded to emergency
 
continuous nebulised department, intensive
salbutamol after considering care unit/high-
other add-on treatment dependency unit)
options Monitor blood
electrolytes, heart
rate and acid/base
balance (blood
lactate)

Reduce initial dose
for older adults.
Consider dose
reduction for those
with impaired renal
function. Impaired
liver function may
result in
accumulation of
unmetabolised
salbutamol

Non-invasive positive Consider if starting to tire or   Do not sedate patient
pressure ventilation  signs of respiratory failure If no improvement,
intubate and start
mechanical
ventilation

Back to top 
Asset ID: 61